Clinical trial Recruiting at 1 site Interventional

Magnesium membrane versus cortical lamina for vestibular socket therapy during immediate implant placement in upper front tooth sockets

Official title: Vestibular Socket Therapy Using Magnesium Membrane Versus Cortical Lamina for Immediate Implant Placement in Type II Extraction Sockets: A Randomized Controlled Clinical Trial

Run by Misr University for Science and Technology · NCT07526272 · Data updated 2026-11-12

This trial tests whether a bioresorbable magnesium membrane helps bone and soft-tissue healing better than a traditional cortical lamina for people receiving immediate implants in Type II maxillary anterior extraction sockets.

Quick facts

Study typeInterventional
SexAll
Enrollment24 (estimated)
SponsorMisr University for Science and Technology
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Giza)
StatusRecruiting
StartedMarch 12, 2026
Main results expectedOctober 2026
Study endsOctober 2026
Registry record updatedApril 13, 2026
Trial IDNCT07526272 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults needing immediate implant placement in maxillary anterior teeth with Type II (deficient labial height) extraction sockets, with at least 3.0 mm of basal bone, who are non-smokers and not pregnant or recently treated with chemo/radiotherapy, are the intended participants.

Probably not a fit

Current smokers, pregnant or lactating individuals, patients with debilitating systemic disease or recent chemotherapy/radiotherapy, or those without sufficient basal bone are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares two barrier materials—a rigid cortical lamina and a bioresorbable magnesium membrane—used with Vestibular Socket Therapy (VST) for immediate implant placement in Type II extraction sockets. VST is a minimally invasive approach that uses a small incision and a subperiosteal tunnel to place a bone shield and graft without raising a full flap. Twenty-four patients are randomized to one of the two materials and followed from baseline to six months with clinical and radiographic assessments of bone fill, implant stability, and soft-tissue outcomes. The trial aims to determine whether the magnesium membrane provides comparable mechanical support and enhanced biological healing compared with the established cortical lamina.

Why it matters

Potential benefit: If successful, the magnesium membrane could provide a resorbable, mechanically supportive barrier that speeds or improves bone regeneration and reduces the need for additional grafting or membrane removal.

How similar studies have gone: Cortical lamina is an established barrier with documented use in socket reconstruction, while magnesium membranes are an emerging, promising technology with encouraging preclinical and early clinical reports but limited long-term human data in immediate implant VST.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Single or multiple teeth with hopeless prognosis in maxillary anterior teeth with either type I or type II extraction sockets.
* Deficient labial bone plate in width (type I) and height (type II) sockets.
* Minimal of 3.0 mm basal bone present for immediate implant placement to achieve optimum primary stability.

Exclusion Criteria:

* Current smokers.
* Patients with debilitating systemic disease.
* Patients who have undergone any sort of radiotherapy and chemotherapy in past 2 years.
* Pregnant and Lactating females.

Where it's running

  • Misr University for Science and Technology
    Giza, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.